ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652151 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652151; 2) Community: the network communities that were significantly associated with the response to NSC 652151; 3) Molecule: the relationships between components within communities and NSC 652151; 4) MDR: the compounds that were significantly associated with the NSC 652151.

NSC Compound Enrichment Correlation
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0222343516878698 -0.053693252
NSC 750743 (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0222343516878698 0.51775327
NSC 752461 Null 0.0222343516878698 0.42416992
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.0222343516878698 0.34448095
NSC 756170 GSK317315A 0.0222343516878698 0.45902995
NSC 12198 Dromostanolone Propionate 0.0244632509325736 0.38116577
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0244632509325736 0.47894843
NSC 169774 Bromocriptine methanesulfonate 0.0244632509325736 0.44427071
NSC 290193 CYCLOSPORIN A 0.0244632509325736 0.41509275
NSC 317908 Null 0.0244632509325736 0.28301219
Total:88  Current:47    [First] [Prev] [Next] [Last]